| |
 |
|
Class Information
Number: 424/188.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.) > Amino acid sequence disclosed in whole or in part; or conjugate, complex, or fusion protein or fusion polypeptide including the same > Disclosed amino acid sequence derived from virus > Retroviridae (e.g., feline leukemia, etc.) > Immunodeficiency virus (e.g., hiv, etc.)
Description: Subject matter wherein the virus is one that is associated with an immunodeficiency syndrome such as AIDS in humans or an AIDS-related syndrome in animals.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 6132721 |
Non-Toxic immunogens derived from a retroviral regulatory protein, antibodies, preparation method therefor, and pharmaceutical compositions containing same |
Oct. 17, 2000 |
| 6121021 |
Constitutive expression of non-infectious HIV-like particles |
Sep. 19, 2000 |
| 6111068 |
HIV-1 p-17 peptide fragments, compositions containing and methods for producing and using same |
Aug. 29, 2000 |
| 6110466 |
Modified plant viruses as vectors |
Aug. 29, 2000 |
| 6103238 |
Selectively deglycosylated human immunodeficiency virus type 1 envelope vaccines |
Aug. 15, 2000 |
| 6103244 |
Methods for generating immune responses employing modified vaccinia of fowlpox viruses |
Aug. 15, 2000 |
| 6103239 |
Modified HGP-30 heteroconjugates, compositions and methods of use |
Aug. 15, 2000 |
| 6093400 |
Modified HGP-30 peptides, conjugates, compositions and methods of use |
Jul. 25, 2000 |
| 6090392 |
HIV envelope polypeptides and vaccine |
Jul. 18, 2000 |
| 6083504 |
Human monoclonal antibodies directed against the transmembrane glycoprotein (GP41) of human immunodeficiency virus-1 (HIV-1) |
Jul. 4, 2000 |
| 6080408 |
Human immunodeficiency virus type 1 nucleic acids devoid of long terminal repeats capable of encoding for non-infectious, immunogenic, retrovirus-like particles |
Jun. 27, 2000 |
| 6074646 |
Nondenatured HIV envelope antigens for detecting early HIV-specific antibodies |
Jun. 13, 2000 |
| 6056963 |
Immunogenic compositions comprising glycosylated and deglycosylated monomeric and dimeric forms of HIV-2 enveloped glycoproteins |
May. 2, 2000 |
| 6048685 |
In vitro diagnostic assay employing HIV-2 antigens for the detection of HIV-2 specific antibodies |
Apr. 11, 2000 |
| 6042831 |
Human immunodeficiency virus type 1 (HIV-1) GP160 epitopes that are immunologically homologous to epitopes located in the class I major histocompatibility complex (MHC) heavy chain .alpha.-1 d |
Mar. 28, 2000 |
| 6042836 |
HIV envelope polypeptides |
Mar. 28, 2000 |
| 6037165 |
Methods for the preparation of human immunodeficiency virus type 2 (HIV-2) and antigens encoped thereby |
Mar. 14, 2000 |
| 6033672 |
Method of stimulating an immune response to caprine arthritis-encephalitis virus (CAEV) in humans through the administration of CAEV immunogens |
Mar. 7, 2000 |
| 6030769 |
Group O HIV-1, fragments of such viruses, and uses thereof |
Feb. 29, 2000 |
| 6025141 |
Immunofluorescence assay for the detection of antibodies using recombinant antigens in insoluble form |
Feb. 15, 2000 |
| 6017543 |
Prevention and treatment of retroviral disease |
Jan. 25, 2000 |
| 6017537 |
Formyl methionyl peptide vaccine adjuvant |
Jan. 25, 2000 |
| 6017536 |
Simian immunodeficiency virus peptides with antifusogenic and antiviral activities |
Jan. 25, 2000 |
| 6015564 |
Cytotoxic T lymphocyte-inducing lipopeptides and use as vaccines |
Jan. 18, 2000 |
| 6015566 |
Peptide composition generating an immune response against herpes virus |
Jan. 18, 2000 |
| 6010895 |
Non-pathogenic strains of HIV-1 containing mutations in the NEF gene or the U3 region of the long terminal repeat |
Jan. 4, 2000 |
| 6004763 |
Antigen-carrying microparticles and their use in the induction of humoral or cellular responses |
Dec. 21, 1999 |
| 5994516 |
Mutated proteins encoded by a lentivirus mutated env gene, peptide fragments and expression vectors |
Nov. 30, 1999 |
| 5993823 |
Cytotoxic T lymphocyte-inducing lipopeptides and methods of use |
Nov. 30, 1999 |
| 5993819 |
Synthetic vaccine for protection against human immunodeficiency virus infection |
Nov. 30, 1999 |
| 5989553 |
Expression library immunization |
Nov. 23, 1999 |
| 5985641 |
Non-infectious, replication-impaired, immunogenic human immunodeficiency virus type 1 retrovirus-like particles with multiple genetic deficiencies |
Nov. 16, 1999 |
| 5981258 |
Composition of trans-dominant variants of viral proteins for obtaining an antiviral effect |
Nov. 9, 1999 |
| 5980900 |
Amino acid DNA sequences related to genomic RNA of human immunodeficiency virus (HIV-1) |
Nov. 9, 1999 |
| 5980901 |
Viral defective interfering particles and uses thereof |
Nov. 9, 1999 |
| 5976541 |
Potent peptide for stimulation of cytotoxic T lymphocytes specific for the HIV-1 envelope |
Nov. 2, 1999 |
| 5976522 |
Lymphocyte chemoattractant factor and uses thereof |
Nov. 2, 1999 |
| 5972339 |
Method of eliciting anti-HIV-1 helper T cell responses |
Oct. 26, 1999 |
| 5968514 |
Methods for stimulating immune responses in a host through the administration of superantigen peptides derived from human immunodeficiency virus type 1 Nef |
Oct. 19, 1999 |
| 5965120 |
Lymphocyte chemoattractant factor and uses thereof |
Oct. 12, 1999 |
| 5965135 |
HIV-1 virus isolates of a subtype and its differential diagnostics |
Oct. 12, 1999 |
| 5965726 |
Method of eliminating inhibitory/ instability regions of mRNA |
Oct. 12, 1999 |
| 5955342 |
Non-infectious, replication-defective, self-assembling HIV-1 viral particles containing antigenic markers in the gag coding region |
Sep. 21, 1999 |
| 5951986 |
Tandem synthetic HIV-1 peptides |
Sep. 14, 1999 |
| 5942401 |
Method of determining favorable prognosis against progressing from an asymptomatic condition to AIDS in an human immunodeficiency virus (HIV) positive subject |
Aug. 24, 1999 |
| 5939074 |
Multideterminant peptide antigens |
Aug. 17, 1999 |
| 5935579 |
AIDS therapy and vaccine |
Aug. 10, 1999 |
| 5932218 |
Multideterminant peptides eliciting helper T-lymphocyte, cytotoxic T-lymphocyte, and neutralizing antibody responses against HIV-1 |
Aug. 3, 1999 |
| 5928930 |
Prevention and treatment of retroviral disease |
Jul. 27, 1999 |
| 5925513 |
Diagnosis and treatment of AIDS onset |
Jul. 20, 1999 |
|
|
|
